Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-mercapto-n-[1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl]acetamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C22H25NO6S and a molecular weight of approximately 431.5 g/mol[1][3][4]. It belongs to the class of organic compounds known as tropones due to its tropone ring structure[2]. The compound is referenced in several chemical databases (DrugBank ID: DB07574; PubChem CID: 5287955; ChemSpider ID: 4450212)[1][3][8]. There are no approved medical indications or clinical trials reported for this molecule as of now—it is classified as experimental and has not advanced beyond preclinical or early research stages[2]. No mechanism of action or biological target has been established in public sources.
- Other names
- 2-Mercapto-N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydro-benzo(A)heptalen-7-YL)acetamide2-sulfanyl-N-(1,2,3,10-tetramethoxy-9-oxo-tricyclo[9.5.0.02,^?]hexadeca-hexaenyl)acetamide2-sulfanyl-N-(7S)-1,2,3,10-tetramethoxybenzo[a]heptalenyl acetamide
Beyond the preview
Go deeper on 2-mercapto-n-[1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl]acetamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-mercapto-n-[1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl]acetamide.